Scopolamine
prevention of nausea and vomiting associated with motion sickness, prevention of post-operative nausea and vomiting (PONV)
Indications
- prevention of nausea and vomiting associated with motion sickness
- prevention of post-operative nausea and vomiting (PONV)
Adult dosing
- motion sickness: dose: 1; unit: patch; route: transdermal - transdermal system delivering 1 mg over 3 days; interval: behind one ear at least 4 h before needed; delivers 1 mg over 3 days; fixed: true; labelExcerpt: Apply one transdermal system to the hairless area behind one ear at least 4 hours before antiemetic effect is required
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consider more frequent monitoring during treatment in patients with hepatic impairment due to increased risk of CNS adverse reactions.
Contraindications
- angle closure glaucoma
- hypersensitivity to scopolamine or other belladonna alkaloids
Clinical pearls
- Apply at least 4 hours before antiemetic effect is needed.
- Do not cut the patch; wash hands thoroughly after application and removal.
- Remove patch and contact provider if hyperthermia or symptoms of acute angle closure glaucoma occur.
- Monitor for CNS effects like hallucinations, confusion, and dizziness, especially in the elderly.
Source and review
- DailyMed label (scopolamine), Set ID 804f580a-a6b9-4dca-b480-be3576682aa9, effective 2026-10-14. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties